Published in Biotech Law Weekly, November 18th, 2005
The formulation is being developed using Nastech's formulation science expertise and high-throughput human tissue culture screening process, a proprietary system for developing large molecule therapeutics that are delivered across the nasal mucosa. Nastech's human tissue culture studies have been demonstrated to have a high correlation with in vivo clinical drug bioavailability.
Proteins and peptides such as insulin are typically delivered by injection because they cannot be delivered orally...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.